Trademark: 79301072
Word
BYVASDA
Status
Registered
Status Code
700
Status Date
Tuesday, August 17, 2021
Serial Number
79301072
Registration Number
6451085
Registration Date
Tuesday, August 17, 2021
Mark Type
5000
Filing Date
Wednesday, November 25, 2020
Published for Opposition
Tuesday, June 1, 2021

Trademark Owner History

Classifications
5 Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for veterinary purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable pharmaceuticals for treatment of anaphylactic reactions

Trademark Events
Feb 20, 2022
Final Decision Transaction Processed By Ib
Feb 2, 2022
Final Disposition Notice Sent To Ib
Feb 2, 2022
Final Disposition Processed
Nov 17, 2021
Final Disposition Notice Created, To Be Sent To Ib
Aug 17, 2021
Registered-Principal Register
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 23, 2021
Approved For Pub - Principal Register
Apr 2, 2021
Teas/Email Correspondence Entered
Apr 1, 2021
Correspondence Received In Law Office
Apr 1, 2021
Teas Response To Office Action Received
Feb 21, 2021
Refusal Processed By Ib
Feb 3, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Feb 3, 2021
Refusal Processed By Mpu
Jan 16, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jan 15, 2021
Non-Final Action Written
Jan 12, 2021
Assigned To Examiner
Jan 6, 2021
Application Filing Receipt Mailed
Jan 2, 2021
New Application Office Supplied Data Entered In Tram
Dec 31, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24